Skip to main content
. 2022 Aug 27;29:25–26. doi: 10.1016/j.jdcr.2022.08.028

Fig 1.

Fig 1

A, Clinical image of the patient’s necrobiosis lipoidica at initial presentation, previously treated with multiple therapeutic modalities. B, Clinical response of the patient’s necrobiosis lipoidica after 3 months of treatment with topical ruxolitinib 1.5% cream and pentoxifylline.